Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Remission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)

This study has been completed.
Hamilton Health Sciences Corporation
Information provided by (Responsible Party):
Dr. Hertzel Gerstein, Population Health Research Institute Identifier:
First received: August 11, 2010
Last updated: October 20, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)